Xbrane Biopharma announces participation in upcoming investor conferences

Corporate Information

English

IR

News

Other Corporate Information

Xbrane Biopharma AB (publ), announce today that its CEO, Martin Åmark, will participate in the following upcoming investor conferences:

Vator Securities Global Healthcare Days in Vienna
Thursday, November 13th, 2019

LSX Inv€$tival Showcase 2019 in London
Tuesday, November 21st, 2019
Presentation at 13:30 GMT (14:30 CET)

Jefferies 2019 Global Healthcare Conference in London
Wednesday, November 20th – Thursday, November 21st, 2019

Vator Securities Unicorn Summit in Stockholm
Wednesday, November 27th, 2019
Presentation at 13:55 CET

Vator Securities Global Healthcare Days in Tel Aviv
Wednesday, December 4th, 2019

Contacts

Martin Åmark, CEO
M: +46 (0) 763-093 777
E: martin.amark@xbrane.com

Susanna Helgesen, CFO
M: +46 (0) 708-278 636
E: susanna.helgesen@xbrane.com

About Us

Xbrane is a commercial phase Swedish biopharmaceutical company that develop and produces biosimilars. Xbrane has a patented protein production platform for development of biosimilars and world leading expertise in biosimilars. Xbrane’s headquarter is located in Solna outside of Stockholm and the company’s in-house research and development facilities are in Sweden and Italy. Xbrane is listed at Nasdaq Stockholm since September 2019 with the ticker XBRANE. For more information please visit www.xbrane.com.

Attachments

Xbrane Biopharma announces participation in upcoming investor conferences